Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Amount of HIV DNA in peripheral blood mononuclear cells is proportional to the severity of HIV-1-associated neurocognitive disorders.

Shiramizu B, Williams AE, Shikuma C, Valcour V.

J Neuropsychiatry Clin Neurosci. 2009 Winter;21(1):68-74. doi: 10.1176/appi.neuropsych.21.1.68.

2.

HIV DNA and dementia in treatment-naïve HIV-1-infected individuals in Bangkok, Thailand.

Shiramizu B, Ratto-Kim S, Sithinamsuwan P, Nidhinandana S, Thitivichianlert S, Watt G, deSouza M, Chuenchitra T, Sukwit S, Chitpatima S, Robertson K, Paul R, Shikuma C, Valcour V.

Int J Med Sci. 2006 Dec 6;4(1):13-8.

3.

Neurological evaluation of untreated human immunodeficiency virus infected adults in Ethiopia.

Clifford DB, Mitike MT, Mekonnen Y, Zhang J, Zenebe G, Melaku Z, Zewde A, Gessesse N, Wolday D, Messele T, Teshome M, Evans S.

J Neurovirol. 2007;13(1):67-72.

PMID:
17454450
4.

[HIV infection associated cognitive disorders].

Manea M, Ruşanu V, Patrichi BE, Stoean R, Pădurariu A, Puiu GM.

Rev Med Chir Soc Med Nat Iasi. 2008 Jul-Sep;112(3):598-601. Romanian.

PMID:
20201238
5.

Circulating HIV DNA Correlates With Neurocognitive Impairment in Older HIV-infected Adults on Suppressive ART.

de Oliveira MF, Murrell B, Pérez-Santiago J, Vargas M, Ellis RJ, Letendre S, Grant I, Smith DM, Woods SP, Gianella S.

Sci Rep. 2015 Nov 25;5:17094. doi: 10.1038/srep17094. Erratum in: Sci Rep. 2016;6:19387. Murrel, Ben [corrected to Murrell, Ben].

6.

Neurovirological correlation with HIV-associated neurocognitive disorders and encephalitis in a HAART-era cohort.

Gelman BB, Lisinicchia JG, Morgello S, Masliah E, Commins D, Achim CL, Fox HS, Kolson DL, Grant I, Singer E, Yiannoutsos CT, Sherman S, Gensler G, Moore DJ, Chen T, Soukup VM.

J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):487-95. doi: 10.1097/QAI.0b013e31827f1bdb.

7.

HIV-1 DNA in peripheral blood mononuclear cells is strongly associated with HIV-1 disease progression in recently infected West African adults.

Minga AK, Anglaret X, d' Aquin Toni T, Chaix ML, Dohoun L, Abo Y, Coulibaly A, Duvignac J, Gabillard D, Rouet F, Rouzioux C.

J Acquir Immune Defic Syndr. 2008 Jul 1;48(3):350-4. doi: 10.1097/QAI.0b013e3181775e55.

PMID:
18545149
8.

HIV-1 RNA concentration and cognitive performance in a cohort of HIV-positive people.

Vitiello B, Goodkin K, Ashtana D, Shapshak P, Atkinson JH, Heseltine PN, Eaton E, Heaton R, Lyman WD.

AIDS. 2007 Jul 11;21(11):1415-22.

PMID:
17589187
9.

Circulating proviral HIV DNA and HIV-associated dementia.

Shiramizu B, Gartner S, Williams A, Shikuma C, Ratto-Kim S, Watters M, Aguon J, Valcour V.

AIDS. 2005 Jan 3;19(1):45-52.

10.

Are MMSE and HDS-R neuropsychological tests adequate for screening HIV-associated neurocognitive disorders?

Nakazato A, Tominaga D, Tasato D, Miyagi K, Nakamura H, Haranaga S, Higa F, Tateyama M, Fujita J.

J Infect Chemother. 2014 Mar;20(3):217-9. doi: 10.1016/j.jiac.2013.10.005. Epub 2014 Jan 18.

PMID:
24462448
11.

Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil.

de Almeida SM, Ribeiro CE, de Pereira AP, Badiee J, Cherner M, Smith D, Maich I, Raboni SM, Rotta I, Barbosa FJ, Heaton RK, Umlauf A, Ellis RJ.

J Neurovirol. 2013 Dec;19(6):550-6. doi: 10.1007/s13365-013-0215-5. Epub 2013 Nov 26.

12.

The incidence of and risk factors for HIV-associated cognitive-motor complex among patients on HAART.

Jevtović Dj, Vanovac V, Veselinović M, Salemović D, Ranin J, Stefanova E.

Biomed Pharmacother. 2009 Sep;63(8):561-5. doi: 10.1016/j.biopha.2008.09.015. Epub 2008 Nov 5.

PMID:
19026516
13.

Neurologic manifestations of human immunodeficiency virus-2: dementia, myelopathy, and neuropathy in West Africa.

Choi Y, Townend J, Vincent T, Zaidi I, Sarge-Njie R, Jaye A, Clifford DB.

J Neurovirol. 2011 Apr;17(2):166-75. doi: 10.1007/s13365-011-0022-9. Epub 2011 Mar 22.

14.

The role of depression chronicity and recurrence on neurocognitive dysfunctions in HIV-infected adults.

Cysique LA, Dermody N, Carr A, Brew BJ, Teesson M.

J Neurovirol. 2016 Feb;22(1):56-65. doi: 10.1007/s13365-015-0368-5. Epub 2015 Aug 25.

PMID:
26304840
15.

Low levels of human immunodeficiency virus type 1 DNA in high-risk seronegative men.

Koning FA, van der Vorst TJ, Schuitemaker H.

J Virol. 2005 May;79(10):6551-3.

16.

Factors influencing peripheral blood mononuclear cell-associated HIV-1 DNA level after long-term suppressive antiretroviral therapy in 236 patients.

Burgard M, Boufassa F, Viard JP, Garrigue I, Ruffault A, Izopet J, Vabret A, Descamps D, Colson P, Seigneurin JM, Rouzioux C; ANRS AC11 Working Group..

AIDS. 2009 Oct 23;23(16):2165-71. doi: 10.1097/QAD.0b013e32833032d4.

PMID:
19657270
17.

Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy.

Furtado MR, Callaway DS, Phair JP, Kunstman KJ, Stanton JL, Macken CA, Perelson AS, Wolinsky SM.

N Engl J Med. 1999 May 27;340(21):1614-22.

18.

Quantitation of human immunodeficiency virus type 1 DNA forms with the second template switch in peripheral blood cells predicts disease progression independently of plasma RNA load.

Kostrikis LG, Touloumi G, Karanicolas R, Pantazis N, Anastassopoulou C, Karafoulidou A, Goedert JJ, Hatzakis A; Multicenter Hemophilia Cohort Study Group..

J Virol. 2002 Oct;76(20):10099-108.

19.

Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. HIV Neurobehavioral Research Center Group.

Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, Abramson I, Atkinson JH, Grant I, McCutchan JA.

Ann Neurol. 1997 Nov;42(5):679-88.

PMID:
9392566
20.

Depression and neurocognitive performance in individuals with HIV/AIDS: 2-year follow-up.

Gibbie T, Mijch A, Ellen S, Hoy J, Hutchison C, Wright E, Chua P, Judd F.

HIV Med. 2006 Mar;7(2):112-21.

Supplemental Content

Support Center